跳至主要内容
临床试验/jRCT2071230090
jRCT2071230090已完成不适用

Phase 1, single dose study of M707102 in healthy subjects

Maruho Co.,Ltd.0 个研究点目标入组 16 人开始时间: 2024年2月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
16
主要终点
-

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized Controlled Trial
干预模型
Parallel Assignment
主要目的
Treatment Purpose
盲法
Double Blind

入排标准

年龄范围
18age old over 至 49age old under(—)
性别
Male

入选标准

  • Male subjects from 18 to 49 years of age (at the time of informed consent)

排除标准

  • (1) Individuals with a history or complications of any of the following diseases
  • Actinic keratosis, porphyria
  • Photosensitivity, metabolic diseases such as aminoaciduria, idiopathic or immune diseases such as polymorphic light eruption, genetic diseases such as xeroderma pigmentosum, and diseases for which onset or exacerbation occur due to exposure to sunlight such as systemic lupus erythematosus and pemphigus
  • (2) Individuals with a history of allergy or hypersensitivity (including skin hypersensitivity) to any ingredient or metabolite of the investigational medicinal product
  • (3) Individuals who are judged to be unsuitable as subject by the principal (sub) investigator

结局指标

主要结局

-

Safety, Pharmacokinetics

次要结局

未报告次要终点

研究者

相似试验